Alpha Teknova (TKNO) Free Cash Flow Growth (3y) (2023 - 2026)
Alpha Teknova (TKNO) Free Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.83 Bn | 32.09 Bn | 1.97 Bn | 9.86% |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | -18.92% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -44.64% |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn | 0.68% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | -27.74% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 46.56% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 39.19% |
| 10 | Alpha Teknova | 261.60 Mn | 243.81 Mn | 3.78 Mn | 33.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.17% |
| Dec 31, 2025 | 60.11% |
| Sep 30, 2025 | 45.86% |
| Jun 30, 2025 | 48.36% |
| Mar 31, 2025 | 27.09% |
| Dec 31, 2024 | 47.68% |
| Sep 30, 2024 | 35.10% |
| Jun 30, 2024 | 28.93% |
| Mar 31, 2024 | -65.07% |
| Dec 31, 2023 | -44.45% |
| Sep 30, 2023 | -109.00% |